John P. Schmid, CFO and Secretary at Trius Therapeutics Inc (TSRX), sold 800 shares at $7.89 ($6K) on 2011-06-01, disclosed to the SEC on 2011-06-01.
Scheduled sale ($6k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.89 | 700 | $6K | 87.3% |
| 2 | $8.00 | 100 | $800 | 12.7% |
| Total | $7.90 avg | 800 | $6K | 100% |
| Filing → |
| XERS | BUY | 2024-08-13 | $10K | — | Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| XERS | BUY | 2024-05-10 | $10K | — | Filing → |